Skip to main content

Advertisement

Fig. 6 | Journal of Translational Medicine

Fig. 6

From: PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Fig. 6

Alteration of migratory, invasive, and proliferative abilities for ESCC cells after PFN2-siRNA transfection. a Representative images and c display of migration and invasion of ECa109 and EC9706 cells transfected with PFN2-siRNA or siRNA-Control and the quantitative analysis are shown in b and d, respectively. b (Bar chart) and d (data) Mean ± SD of three biological replicates (**P < 0.01, ***P < 0.001). The quantitative analysis of proliferative capability of ECa109, EC9706, and TE-1 cells transfected with PFN2-siRNA or siRNA-Control is exhibited in e, f, g. Plots are represented as mean ± SD of data from three independent experiments

Back to article page